Hypertension
The production of angiotensinogen is increased by corticosteroids, estrogens, thyroid hormones, and ANG II.
It can increase blood pressure by constricting the blood vessels. It can also trigger thirst or the desire for salt. Angiotensin is responsible for the release of the pituitary gland's anti-diuretic hormone.
Angiotensin blockers do not affect the metabolism of bradykinin which is responsible for the side effect of a dry cough, it decreases the renin produced. ACE inhibitors affect the metabolism of bradykinin therefore the side effect of dry cough is experienced. It also has a serious vasodilating effect.
ACE inhibitors block the conversion ANG I and ANG II it also blocks the metabolism of bradykinin to an inactive metabolite. ANG II causes an increase in Blood pressure thus by blocking the conversion of ANG I to ANG II ACE inhibitors decrease blood pressure significantly.
Losartan, is a selective non-peptide antagonist blocking the AT1 receptors. They influence AT2 receptors when Angiotensin 2 is increased.
Kinins are proteins in the blood that cause inflammation and affect blood pressure (especially low blood pressure). They also: Increase blood flow throughout the body. Make it easier for fluids to pass through small blood vessels. Through bradykinin ability to elevate vascular permeability and to cause vasodilatation in some arteries and veins. Kinins are potent vasodilators and increase the blood flow in the body.Autocoids such as Histamine and Serotonin also play a role in this action Histamine - H1 and H2 receptors dilatate blood vessels and capillaries.
Kinins are a family of peptides implicated in several pathophysiological events. Most of their effects are likely mediated by the activation of two G-protein-coupled receptors: B1 and B2.
Agonists binding to ANP receptors cause vasodilation with increased glomerular filtration rate and enhanced Na+ and water excretion, while BNP receptor stimulation inhibits renin production. These peptides reduce blood pressure through vasodilation of both the arterial and venous systems
Neprilysin enzyme is also called neutral endopeptidase that plays a role in the degradation of natriuretic peptides and other vasoactive peptides including bradykinin. Natriuretic peptides remove sodium from the blood and excrete it in the urine.
Neprilysin inhibitors are a new class of drugs used to treat high blood pressure and heart failure. They work by blocking the action of neprilysin thus preventing the breakdown of natriuretic peptides. The drug used is sacubitril
Vasodilators – Nitric Oxide
Vasoconstrictors - ET1